A patient with a cerebral vasospasm is receiving triple H therapy. What parameter should the nurse use to determine adequacy of hemodilution?

Question

Quizplus · Accepted Answer

Hemodilution is part of triple H therapy (hypertension, hypervolemia, hemodilution) used to treat cerebral vasospasm. The goal is to reduce blood viscosity to improve cerebral blood flow. Adequacy of hemodilution is determined by monitoring hemoglobin levels, aiming for a lower level to ensure the blood is sufficiently diluted. However, the hemoglobin level of 30 g/dL mentioned in option A is incorrect as it is far too high and likely a typographical error. In clinical practice, a target hemoglobin level would be lower, typically around 30-35% hematocrit or a hemoglobin level of around 10 g/dL, to ensure adequate dilution without compromising oxygen-carrying capacity. The other options (B, C, D) are not direct indicators of hemodilution adequacy.

A Patient with a Cerebral Vasospasm Is Receiving Triple H